Get the Stockscreener App
22.26
15.02%
2.88
Stevanato Group Spa stock is traded at $22.26, with a volume of 1.29M.
It is up +15.02% in the last 24 hours and up +17.50% over the past month.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
See More
Previous Close:
$19.38
Open:
$19.28
24h Volume:
1.29M
Relative Volume:
2.61
Market Cap:
$6.84B
Revenue:
$1.18B
Net Income/Loss:
$132.61M
P/E Ratio:
37.32
EPS:
0.5964
Net Cash Flow:
$-276.17M
1W Performance:
+18.56%
1M Performance:
+17.50%
6M Performance:
-15.73%
1Y Performance:
-16.42%
1-Day Range:
$19.28
$22.50
1-Week Range:
$18.37
$22.50
52-Week Range:
$16.56
$34.73
Stevanato Group Spa Stock (STVN) Company Profile
Name
Stevanato Group Spa
Sector
Industry
Phone
-
Address
-
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-24 | Initiated | Exane BNP Paribas | Outperform |
| Nov-01-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-26-23 | Initiated | Stephens | Overweight |
| Sep-19-23 | Initiated | CJS Securities | Market Outperform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-10-21 | Initiated | BofA Securities | Buy |
| Aug-10-21 | Initiated | Citigroup | Buy |
| Aug-10-21 | Initiated | Jefferies | Buy |
| Aug-10-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-10-21 | Initiated | Morgan Stanley | Overweight |
| Aug-10-21 | Initiated | Wells Fargo | Overweight |
View All
Stevanato Group Spa Stock (STVN) Latest News
Stevanato: Q3 Earnings Snapshot - San Antonio Express-News
Stevanato Group Reports Financial Results for the Third Quarter of 2024 - The Bakersfield Californian
What's Next: Stevanato Gr's Earnings Preview - Benzinga
Stevanato Group SpA (STVN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
(STVN) On The My Stocks Page - Stock Traders Daily
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt - Simply Wall St
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 - Business Wire
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
nVerses Capital LLC Takes Position in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Stevanato Group S.p.A.: Expansion & Efficiency In Product Lines & Other Major Drivers - Smartkarma
How the (STVN) price action is used to our Advantage - Stock Traders Daily
Squarepoint Ops LLC Purchases 6,853 Shares of Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Pharmaceutical Visual Inspection Systems Market: Detailed - openPR
The Manufacturers Life Insurance Company Boosts Position in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Check Out Stevanato Group Spa (STVN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Financial Fitness Check: Examining Stevanato Group Spa (STVN)’s Key Ratios - The Dwinnex
Objective long/short (STVN) Report - Stock Traders Daily
Stevanato Group Spa (STVN)’s stock price in review: A technical analysis - US Post News
Stevanato Group Introduces Large-Volume Vertiva On-Body Delivery System - Contract Pharma
Stevanato Group Spa (STVN) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Market Recap Check: Stevanato Group Spa (STVN)’s Negative Finish at 20.00, Up/Down -6.24 - The Dwinnex
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan - StockTitan
Is Stevanato Group S.p.A. (STVN) the Top Italian Stock for Biopharma Investors? - Insider Monkey
Sei Investments Co. Trims Stake in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Stevanato Group SpA (STVN) Shares Up 4.27% on Sep 27 - GuruFocus.com
Blair William & Co. IL Purchases Shares of 21,105 Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Here’s Why ClearBridge SMID Cap Growth Strategy Exited Stevanato (STVN) - Insider Monkey
Stevanato, Gerresheimer, SCHOTT Form Alliance For RTU - Contract Pharma
Stevanato and partners form alliance to boost RTU container use By Investing.com - Investing.com Australia
Stevanato Group S.p.A. (NYSE:STVN) Shares Acquired by Fred Alger Management LLC - Defense World
Stevanato and partners form alliance to boost RTU container use - Investing.com
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU” - Business Wire
EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU” - finanzen.at
Pharmaceutical Glass Packaging Market Trends and Growth - openPR
First Light Asset Management LLC Reduces Stake in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Tri Locum Partners LP Takes Position in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
565,422 Shares in Stevanato Group S.p.A. (NYSE:STVN) Purchased by Tri Locum Partners LP - MarketBeat
(STVN) Technical Data - Stock Traders Daily
Stevanato Group (NYSE:STVN) Shares Up 3.4% - Defense World
Stevanato Group Spa (STVN) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Stevanato Group (NYSE:STVN) Trading 3.4% Higher - MarketBeat
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Top investors say Stevanato Group Spa (STVN) ticks everything they need - SETE News
Do Fundamentals Have Any Role To Play In Driving Stevanato Group S.p.A.'s (NYSE:STVN) Stock Up Recently? - Yahoo Finance
Dual Chamber Prefilled Syringes Market Size is Projected to Reach US$ 5,495.5 Million by 2034 | Fact.MR - GlobeNewswire Inc.
Stevanato Group Spa (STVN) shows promising results - US Post News
Investor’s Toolkit: Key Ratios for Assessing Stevanato Group Spa (STVN)’s Performance - The Dwinnex
Is Stevanato Group S.p.A.'s (NYSE:STVN) Recent Stock Performance Influenced By Its Financials In Any Way? - Simply Wall St
Stevanato Group S.p.A. (NYSE:STVN) Shares Acquired by TD Asset Management Inc - Defense World
Thornburg Investment Management Inc. Purchases 549,378 Shares of Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Here’s What Weighed on Stevanato Group S.p.A.’s (STVN) Results - Insider Monkey
Stevanato Group Spa Stock (STVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):